Sunscreening

Prescribable sunscreens for ACBS conditions

Prescriptions should be endorsed “ACBS”.

Anthelios
Anthelios sunscreen lotion SPF 50+

Apply as required.

Prescriptions should be endorsed “ACBS”. Note that some pack sizes of Uvistat sun cream are discontinued.

Uvistat
Uvistat sun cream SPF 30

Apply as required.

Uvistat sun cream SPF 50

Apply as required.

Uvistat lipscreen SPF 50

Apply as required.

Prescribing Notes:

  • The choice of sunscreen depends on individual patient need, tolerance and evidence of sensitivity to excipients.
  • The Advisory Committee on Borderline Substances (ACBS) criteria for its listed sunscreens are “When prescribed for skin protection against ultraviolet radiation and/or visible light in abnormal cutaneous photosensitivity causing severe cutaneous reactions in genetic disorders (including xeroderma pigmentosum and porphyrias), severe photodermatoses (both idiopathic and acquired) and in those with increased risk of ultraviolet radiation causing severe adverse effects due to chronic disease (such as haematological malignancies), medical therapies and/or procedures.
  • Prescriptions should be endorsed “ACBS”.
  • For optimum photoprotection, sunscreen preparations should be applied thickly.

History Notes

02/07/2024

Addition of 'Anthelios sunscreen lotion SPF 50+'. ERFC 29/05/2024

29/09/2022

Sunsense ACBS product discontinued.

15/12/2021

East Region Formulary content agreed.

Prescribable sunscreens for ACBS conditions

Prescriptions should be endorsed “ACBS”.

Anthelios
Anthelios sunscreen lotion SPF 50+

Apply as required.

Prescriptions should be endorsed “ACBS”. Note that some pack sizes of Uvistat sun cream are discontinued.

Uvistat
Uvistat sun cream SPF 30

Apply as required.

Uvistat sun cream SPF 50

Apply as required.

Uvistat lipscreen SPF 50

Apply as required.

Prescribing Notes:

  • The choice of sunscreen depends on individual patient need, tolerance and evidence of sensitivity to excipients.
  • The Advisory Committee on Borderline Substances (ACBS) criteria for its listed sunscreens are “When prescribed for skin protection against ultraviolet radiation and/or visible light in abnormal cutaneous photosensitivity causing severe cutaneous reactions in genetic disorders (including xeroderma pigmentosum and porphyrias), severe photodermatoses (both idiopathic and acquired) and in those with increased risk of ultraviolet radiation causing severe adverse effects due to chronic disease (such as haematological malignancies), medical therapies and/or procedures.
  • Prescriptions should be endorsed “ACBS”.
  • For optimum photoprotection, sunscreen preparations should be applied thickly.

History Notes

31/05/2024

East Region Formulary content agreed.